As STAT3 is a pivotal regulator of cellular metabolism under physiological conditions, an ideal STAT3-targeted agent should minimize its toxicities in normal cells while preserving its specificity and efficacy against tumor-associated components. Here, STAT3 is linked to neoplasm.